Cargando…
Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling
BACKGROUND: The role of JAM3 in different tumors is controversial. The epigenetic regulation and the mechanism of JAM3 remain to be elucidated in human esophageal cancer (EC). METHODS: Eleven EC cell lines, 49 cases of esophageal intraepithelial neoplasia (EIN) and 760 cases of primary EC samples we...
Autores principales: | Yang, Weili, Guo, Chao, Herman, James G., Zhu, Cheng, Lv, Honghui, Su, Xiaomo, Zhang, Lirong, Zhang, Meiying, Guo, Mingzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719220/ https://www.ncbi.nlm.nih.gov/pubmed/36461092 http://dx.doi.org/10.1186/s13148-022-01388-3 |
Ejemplares similares
-
Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020) -
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
por: Dong, Yan, et al.
Publicado: (2015) -
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017) -
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018) -
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)